{
  "docId": "019dd923-605d-726d-81a5-0b14357c6be4",
  "docSlug": "bi-c034b4dadeb3c409",
  "documentTitle": "See the pitch deck Theranica used for a $25 million Series C",
  "authorId": "Pitchdecks",
  "authorName": "Theranica",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 13,
  "pageCount": 22,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide uses a bar chart to visually demonstrate that Nerivio has a significantly lower adverse event (AE) rate compared to pharmaceutical alternatives.",
  "elementsJson": [
    "action_title",
    "paragraph",
    "bar_chart_vertical",
    "photo",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-605d-726d-81a5-0b14357c6be4/13",
  "deckHref": "/decks/019dd923-605d-726d-81a5-0b14357c6be4",
  "deckJsonHref": "/decks/019dd923-605d-726d-81a5-0b14357c6be4.json",
  "deckAnchorHref": "/decks/019dd923-605d-726d-81a5-0b14357c6be4#slide-13",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Less than 5% of patients with an AE with Nerivio",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c5b3-77ee-88e2-e5e638daa201",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.5,
        "x": 0.45,
        "y": 0.05
      },
      "kind": "chart",
      "text": "Lowest side-effect rate comparison",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d03c1c90-74a7-4f52-8ec3-3d29c1f2d738",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "image",
      "text": "Nerivio product packaging and device",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72cbaa10-9881-4a68-91dd-a1dca10cf1da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.4,
        "y": 0.75
      },
      "kind": "list",
      "text": "No systemic side effects; No concern of drug-drug interaction; No abuse risk at any number of uses; No risk of medication overuse",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "308dd797-6619-42b4-8d8d-095602ddf196",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "side-effect rate: 4.8%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-c5b3-77ee-88e2-eb7f00ceefcc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "All Nerivio AE's were mild, and resolved shortly after the end of treatment",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc671d59-c738-449c-ba49-6bab64b44b35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "...but with lower rate and milder side effects",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a025fbc-f505-4989-a5eb-a4054a67b29a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "3aa121ba-9ef5-4ab2-97ef-e44238de541e",
      "evidence": "Direct comparison of side-effect rates against competitors",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 5,
      "beatId": "eeab2ed6-c433-4b01-b5e5-4874e72da53b",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The deck presents evidence and data to support the solution",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "45412f7d-a3d6-4701-935b-ced450dc2d08",
      "evidence": "The deck mentions evidence-based cost savings",
      "position": 0,
      "objective": "Highlight the cost of not using Theranica's solution",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 22,
      "from": 2,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "f86ab2e5-ee72-497c-8f42-28187d41914c",
      "evidence": "The deck presents the company's mission and solution",
      "position": 1,
      "objective": "Explain why Theranica's solution is necessary and how it works",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}